128 related articles for article (PubMed ID: 34954894)
1. Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer.
Zhang Y; Wei H; Zhou Y; Li Z; Gou W; Meng Y; Zheng W; Li J; Li Y; Zhu W
Clin Transl Med; 2021 Dec; 11(12):e649. PubMed ID: 34954894
[No Abstract] [Full Text] [Related]
2. SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance.
Li J; Wu R; Yung MMH; Sun J; Li Z; Yang H; Zhang Y; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Zheng W; Wei H; Gao Y; Nemes P; Pei H; Chan DW; Li Y; Zhu W
Cell Death Dis; 2021 Apr; 12(4):341. PubMed ID: 33795649
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
Wei H; Guo J; Sun X; Gou W; Ning H; Shang H; Liu Q; Hou W; Li Y
J Nat Prod; 2022 May; 85(5):1248-1255. PubMed ID: 35500202
[TBL] [Abstract][Full Text] [Related]
4. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
5. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
[TBL] [Abstract][Full Text] [Related]
6. DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.
Meng Y; Chen CW; Yung MMH; Sun W; Sun J; Li Z; Li J; Li Z; Zhou W; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Kai Y; Peng W; Tzatsos A; Li Y; Dai Z; Zheng W; Chan DW; Zhu W
Cancer Lett; 2018 Aug; 428():104-116. PubMed ID: 29704517
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
[TBL] [Abstract][Full Text] [Related]
8. Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.
Wei H; Guo J; Sun X; Gou W; Ning H; Fang Z; Liu Q; Hou W; Li Y
Eur J Med Chem; 2022 Jan; 227():113918. PubMed ID: 34688014
[TBL] [Abstract][Full Text] [Related]
9. Clinical reversal of drug resistance in ovarian cancer.
Ozols RF; O'Dwyer PJ; Hamilton TC
Gynecol Oncol; 1993 Oct; 51(1):90-6. PubMed ID: 8244181
[TBL] [Abstract][Full Text] [Related]
10. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
Witty J; Aguilar-Martinez E; Sharrocks AD
Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of drug resistance in ovarian cancer.
Johnson SW; Ozols RF; Hamilton TC
Cancer; 1993 Jan; 71(2 Suppl):644-9. PubMed ID: 8420689
[TBL] [Abstract][Full Text] [Related]
12. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
13. DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling.
Li J; Pan C; Boese AC; Kang J; Umano AD; Magliocca KR; Yang W; Zhang Y; Lonial S; Jin L; Kang S
Clin Cancer Res; 2020 Jul; 26(14):3843-3855. PubMed ID: 32341033
[TBL] [Abstract][Full Text] [Related]
14. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
[TBL] [Abstract][Full Text] [Related]
15. SENP1 regulates PTEN stability to dictate prostate cancer development.
Bawa-Khalfe T; Yang FM; Ritho J; Lin HK; Cheng J; Yeh ET
Oncotarget; 2017 Mar; 8(11):17651-17664. PubMed ID: 27852060
[TBL] [Abstract][Full Text] [Related]
16. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.
Benabbou N; Mirshahi P; Cadillon M; Soria J; Therwath A; Mirshahi M
Int J Oncol; 2013 Sep; 43(3):685-94. PubMed ID: 23857432
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy.
Ferraresi A; Esposito A; Girone C; Vallino L; Salwa A; Ghezzi I; Thongchot S; Vidoni C; Dhanasekaran DN; Isidoro C
Cells; 2021 Nov; 10(11):. PubMed ID: 34831435
[No Abstract] [Full Text] [Related]
18. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
19. SENP1/HIF-1α axis works in angiogenesis of human dental pulp stem cells.
Zhou J; Sun C
J Biochem Mol Toxicol; 2020 Mar; 34(3):e22436. PubMed ID: 31953908
[TBL] [Abstract][Full Text] [Related]
20. Confluence analysis of multiple omics on platinum resistance of ovarian cancer.
Ye X
Eur J Gynaecol Oncol; 2015; 36(5):514-9. PubMed ID: 26513874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]